CSR1 suppresses tumor growth and metastasis of prostate cancer

48Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Prostate cancer is frequent among men over 45 years of age, but it generally only becomes lethal with metastasis. In this study, we identified a gene called cellular stress response 1 (CSR1) that was frequently down-regulated and methylated to prostate cancer samples. Survival analysis indicated that methylation of the CSR1 promoter, and to a lesser extent down-regulation of CSR1 protein expression, was associated with a high rate of prostate cancer metastasis. Forced expression of CSR1 in prostate cancer cell lines DU145 and PC3 resulted in a two- to threefold decrease to colony formation and a 10-fold reduction to anchorage-independent growth. PC3 cells stably expressing CSR1 had an average threefold decrease in their ability to invade in vitro. Expression of CSR1 to PC3 cell xenografts produced a dramatic reduction (>8-fold) in tumor size, rate of invasion (0 versus 31%), and mortality (13 versus 100%). The present findings suggest that CSR1 is a potent tumor suppressor gene. Copyright © American Society for Investigative Pathology.

Cite

CITATION STYLE

APA

Yu, G., Tseng, G. C., Yu, Y. P., Gavel, T., Nelson, J., Wells, A., … Luo, J. H. (2006). CSR1 suppresses tumor growth and metastasis of prostate cancer. American Journal of Pathology, 168(2), 597–607. https://doi.org/10.2353/ajpath.2006.050620

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free